Graphic: Vioxx Legal Resources.com
Offices

Image: Gavel & Law Books
Attorney Advertising Disclaimer

 


Vioxx News Article
March 13, 2007
First Coast News, "Vioxx Jury Awards $47.5M to Idaho Couple"
          Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and hitting Merck with a total of $47.5 million in damages. In one of Merck's biggest losses over the drug so far, the jurors awarded the man and his wife $20 million in compensatory damages Monday morning, then later said Merck should pay $27.5 million in punitive damages.
          The verdict in the case of Frederick "Mike" Humeston, who was granted a second trial in light of new evidence, means Merck has now won nine cases and lost five in the mushrooming litigation over its former blockbuster arthritis pill. Humeston, 61, of Boise, Idaho, suffered a heart attack in September 2001, several months before Merck - under pressure from federal regulators - put a stronger warning about the cardiovascular risks of Vioxx on the drug's detailed package insert.
          The five-man, three-woman jury ruled on March 2 that Merck was negligent and did not provide adequate warning about those risks before Humeston's heart attack. The jurors, after deliberating for about five hours over two days, awarded Humeston $18 million in compensatory damages for pain and suffering and gave $2 million to his wife, Mary. Then, after brief arguments over punitive damages, the jury deliberated briefly late Monday afternoon and decided to assess $27.5 million in punitive damages against Merck. "This is why you keep fighting," said Humeston's lawyer. "A little guy from Idaho took on Merck and beat them big time."

Lieff Cabraser: Experienced Vioxx Injury Lawyers
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over-fifty attorney law firm with offices in San Francisco, New York and Nashville. In each of the last five years, the National Law Journal has recognized Lieff Cabraser as one of the top plaintiffs’ law firms in America.
For our personal injury Vioxx cases, we bring a team of experienced lawyers. In addition, we have on staff multiple nurses, legal assistants, scientific analysts and case clerks to assist our Vioxx attorneys. Learn more about advantages we offer patients with Vioxx problems and injuries.
OUR PROMISE TO YOU
We have a nationwide team of experienced injury Vioxx lawyers assigned to Vioxx trials.
We provide individual attentive service. Learn more about our firm.
We have retained the leading national medical experts on Vioxx and have a staff of nurses to assist the prosecution of the claims of our clients.
We have been contacted by thousands of Vioxx drug patients nationwide as part of the Vioxx litigation. We have represented patients who ingested prescription drugs with dangerous, undisclosed side effects in personal injury lawsuits across America, including residents of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming.
Persons living outside the United States who have been injured by an American product manufactured may also in certain cases file Vioxx lawsuits for compensation for heart attacks and strokes in United States courts.

Photo: Supreme Court, Gavel & Law Books, Scales, various pill images
Lieff Cabraser Heimann & Bernstein, LLP

Trademark Notice
"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP

Vioxx Recall: The international prescription drug company Merck announced in September 2004 the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke.

Vioxx Trial: Patients who have suffered injuries due to Vioxx have filed litigation against Merck for selling Vioxx even though Merck allegedly was aware of Vioxx's dangerous side effects.